NasdaqGS:GEHCMedical Equipment
FDA Clears GE HealthCare AI Tool Aiming At Faster Cancer Planning
GE HealthCare Technologies (NasdaqGS:GEHC) received FDA clearance for its MIM Contour ProtégéAI+ 2.0 software.
The AI enabled tool is designed to support more automated and precise radiation therapy planning for cancer patients.
The clearance includes a Predetermined Change Control Plan that allows future AI features to be deployed more quickly.
For investors watching GE HealthCare's oncology and imaging efforts, this update adds another piece to the broader medical technology story. The...